Institute For Myeloma And Bone Cancer Research
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 705,877 | 1,038,773 | −332,896 | -4.4 | 31% |
| 2012 | 876,465 | 846,779 | 29,686 | -4.9 | 29% |
| 2013 | 889,195 | 922,532 | −33,337 | -5.0 | 38% |
| 2014 | 1,213,638 | 1,468,188 | −254,550 | -5.2 | 27% |
| 2015 | 1,214,577 | 1,203,772 | 10,805 | -6.0 | 0% |
| 2016 | 1,027,818 | 1,199,245 | −171,427 | -7.8 | 2% |
| 2017 | 1,662,275 | 887,526 | 774,749 | 6.1 | 0% |
| 2018 | 1,023,481 | 1,654,660 | −631,179 | -1.3 | 0% |
| 2019 | 584,714 | 3,370,596 | −2,785,882 | -10.6 | 11% |
| 2020 | 2,661,444 | 1,404,338 | 1,257,106 | -14.6 | 30% |
| 2021 | 1,373,547 | 2,654,225 | −1,280,678 | -13.5 | 14% |
| 2022 | 2,303,328 | 1,450,344 | 852,984 | -17.7 | 24% |
| 2023 | 1,146,011 | 1,293,096 | −147,085 | -21.2 | 19% |
In its most recent public year (2023), this organization spent $147,085 more than it brought in. Its liabilities exceeded its net assets — reserves were below zero (-21.2 months), down from -4.4 in 2011. Staff pay was 19% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Institute For Myeloma And Bone Cancer Research's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works